New Results
Immunogenicity of one- and two-dose regimens of the Ad26.COV2.S COVID-19 vaccine candidate in adult and aged rhesus macaques
View ORCID ProfileLaura Solforosi, Harmjan Kuipers, Sietske K. Rosendahl Huber, View ORCID ProfileJoan E.M. van der Lubbe, Liesbeth Dekking, Dominika N. Czapska-Casey, Ana Izquierdo Gil, Miranda R.M. Baert, Joke Drijver, Joost Vaneman, Ella van Huizen, Ying Choi, Jessica Vreugdenhil, View ORCID ProfileTim J. Dalebout, View ORCID ProfileSebenzile K. Myeni, View ORCID ProfileMarjolein Kikkert, View ORCID ProfileEric J. Snijder, View ORCID ProfileDan H. Barouch, View ORCID ProfileGerrit Koopman, View ORCID ProfilePetra Mooij, View ORCID ProfileWilly M.J.M. Bogers, View ORCID ProfileLeacky Muchene, Jeroen T.B.M. Tolboom, View ORCID ProfileRamon Roozendaal, View ORCID ProfileHanneke Schuitemaker, View ORCID ProfileFrank Wegmann, Roland C. Zahn
doi: https://doi.org/10.1101/2020.11.17.368258
Laura Solforosi
1Janssen Vaccines and Prevention B.V., Leiden, The Netherlands
Harmjan Kuipers
1Janssen Vaccines and Prevention B.V., Leiden, The Netherlands
Sietske K. Rosendahl Huber
1Janssen Vaccines and Prevention B.V., Leiden, The Netherlands
Joan E.M. van der Lubbe
1Janssen Vaccines and Prevention B.V., Leiden, The Netherlands
Liesbeth Dekking
1Janssen Vaccines and Prevention B.V., Leiden, The Netherlands
Dominika N. Czapska-Casey
1Janssen Vaccines and Prevention B.V., Leiden, The Netherlands
Ana Izquierdo Gil
1Janssen Vaccines and Prevention B.V., Leiden, The Netherlands
Miranda R.M. Baert
1Janssen Vaccines and Prevention B.V., Leiden, The Netherlands
Joke Drijver
1Janssen Vaccines and Prevention B.V., Leiden, The Netherlands
Joost Vaneman
1Janssen Vaccines and Prevention B.V., Leiden, The Netherlands
Ella van Huizen
1Janssen Vaccines and Prevention B.V., Leiden, The Netherlands
Ying Choi
1Janssen Vaccines and Prevention B.V., Leiden, The Netherlands
Jessica Vreugdenhil
1Janssen Vaccines and Prevention B.V., Leiden, The Netherlands
Tim J. Dalebout
2Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands
Sebenzile K. Myeni
2Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands
Marjolein Kikkert
2Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands
Eric J. Snijder
2Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands
Dan H. Barouch
3Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
Gerrit Koopman
4Department of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands
Petra Mooij
4Department of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands
Willy M.J.M. Bogers
4Department of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands
Leacky Muchene
1Janssen Vaccines and Prevention B.V., Leiden, The Netherlands
Jeroen T.B.M. Tolboom
1Janssen Vaccines and Prevention B.V., Leiden, The Netherlands
Ramon Roozendaal
1Janssen Vaccines and Prevention B.V., Leiden, The Netherlands
Hanneke Schuitemaker
1Janssen Vaccines and Prevention B.V., Leiden, The Netherlands
Frank Wegmann
1Janssen Vaccines and Prevention B.V., Leiden, The Netherlands
Roland C. Zahn
1Janssen Vaccines and Prevention B.V., Leiden, The Netherlands
Posted November 17, 2020.
Immunogenicity of one- and two-dose regimens of the Ad26.COV2.S COVID-19 vaccine candidate in adult and aged rhesus macaques
Laura Solforosi, Harmjan Kuipers, Sietske K. Rosendahl Huber, Joan E.M. van der Lubbe, Liesbeth Dekking, Dominika N. Czapska-Casey, Ana Izquierdo Gil, Miranda R.M. Baert, Joke Drijver, Joost Vaneman, Ella van Huizen, Ying Choi, Jessica Vreugdenhil, Tim J. Dalebout, Sebenzile K. Myeni, Marjolein Kikkert, Eric J. Snijder, Dan H. Barouch, Gerrit Koopman, Petra Mooij, Willy M.J.M. Bogers, Leacky Muchene, Jeroen T.B.M. Tolboom, Ramon Roozendaal, Hanneke Schuitemaker, Frank Wegmann, Roland C. Zahn
bioRxiv 2020.11.17.368258; doi: https://doi.org/10.1101/2020.11.17.368258
Immunogenicity of one- and two-dose regimens of the Ad26.COV2.S COVID-19 vaccine candidate in adult and aged rhesus macaques
Laura Solforosi, Harmjan Kuipers, Sietske K. Rosendahl Huber, Joan E.M. van der Lubbe, Liesbeth Dekking, Dominika N. Czapska-Casey, Ana Izquierdo Gil, Miranda R.M. Baert, Joke Drijver, Joost Vaneman, Ella van Huizen, Ying Choi, Jessica Vreugdenhil, Tim J. Dalebout, Sebenzile K. Myeni, Marjolein Kikkert, Eric J. Snijder, Dan H. Barouch, Gerrit Koopman, Petra Mooij, Willy M.J.M. Bogers, Leacky Muchene, Jeroen T.B.M. Tolboom, Ramon Roozendaal, Hanneke Schuitemaker, Frank Wegmann, Roland C. Zahn
bioRxiv 2020.11.17.368258; doi: https://doi.org/10.1101/2020.11.17.368258
Subject Area
Subject Areas
- Biochemistry (11752)
- Bioengineering (8752)
- Bioinformatics (29200)
- Biophysics (14974)
- Cancer Biology (12096)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18308)
- Genetics (12245)
- Genomics (16803)
- Immunology (11869)
- Microbiology (28097)
- Molecular Biology (11594)
- Neuroscience (60969)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2886)
- Systems Biology (7340)
- Zoology (1651)